Login
Keen Vision Acquisition Corp logo

Keen Vision Acquisition Corp

kv-ac.com

What Do They Do?

Seeks to merge with a business, focusing on biotechnology, consumer goods, and agriculture companies.

How Do They Make Money?

No revenue reported yet.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q2 FY2026, the three months to Jun 30, 2026
Net income
▼ Now a loss
vs $558.1K in Q2 FY2025
  • Jul 30, 2026 Nasdaq securities face delisting; company will not appeal Trading is scheduled to be suspended on August 3, 2026, and the securities are expected to trade over the counter.
  • Apr 15, 2026 Deadline extended to negotiate a replacement merger agreement with Medera and Novoheart The deadline to negotiate the replacement merger agreement was extended from April 10 to April 30, 2026.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support